Levothyroxine sodium
- Product NDC
- 51655-739
- 11-digit product format
- 516550739
- Labeler code
- 51655
- Product ID
- 51655-739_4a7a6787-eb68-76e8-e063-6394a90a9b1b
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Levothyroxine Sodium
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Northwind Health Company, LLC
- Application
- ANDA212399
- Marketing category
- ANDA
- Marketing start
- 2021-06-28
- Substance
- LEVOTHYROXINE SODIUM
- Active strength
- 50 ug/1
- Pharmacologic classes
- Thyroxine [CS], l-Thyroxine [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
Related UNII Ingredients
| UNII | Preferred term | Registry number | Matched term |
|---|
| 9J765S329G | LEVOTHYROXINE SODIUM | 6106-07-6 | LEVOTHYROXINE SODIUM |
Packages
| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|
| 51655-739-52 | 51655073952 | 30 TABLET in 1 BOTTLE, PLASTIC (51655-739-52) | 30 tablet | 2021-06-28 | No | No | Historical |
Related DailyMed Labels
| Title | Manufacturer | Effective date | Type | Version |
|---|
| Levothyroxine sodium | Northwind Health Company, LLC | 2026-01-01 | HUMAN PRESCRIPTION DRUG LABEL | 4 |